Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

TF Financial (THRD) Stock Forecast & Price Target

TF Financial logo
Get the Latest News and Ratings for THRD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for TF Financial and its competitors.

Sign Up

THRD Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
0 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$20.33$20.33$20.33$5.30
Forecasted Upside74.99% Upside51.85% Upside57.75% Upside-29.43% Downside
Consensus Rating
Buy
Buy
Buy
Hold

THRD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

THRD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

TF Financial Stock vs. The Competition

TypeTF FinancialMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside74.99% Upside27,482.23% Upside9.87% Upside
News Sentiment Rating
Neutral News

See Recent THRD News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/9/2024Morgan Stanley
3 of 5 stars
 UpgradeEqual Weight ➝ Overweight$12.00 ➝ $20.00+84.16%
6/18/2024Stifel Nicolaus
4 of 5 stars
 Initiated CoverageBuy$23.00+77.61%
6/7/2024Raymond James
4 of 5 stars
 Initiated CoverageOutperform$18.00+29.96%
12/16/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$30.00 ➝ $3.60-16.28%
12/15/2022Lifesci Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slutsky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:41 PM ET.


THRD Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for TF Financial is $20.33, with a high forecast of $23.00 and a low forecast of $18.00.

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TF Financial in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" THRD shares.

According to analysts, TF Financial's stock has a predicted upside of 74.99% based on their 12-month stock forecasts.

Analysts like TF Financial more than other "medical" companies. The consensus rating for TF Financial is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how THRD compares to other companies.


This page (NASDAQ:THRD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners